In 2022, China's foreign trade of traditional Chinese medicine products maintained a relatively stable growth trend, with a total foreign trade volume of 8.57 billion US dollars, a year-on-year increase of 10.7%. Among them, the export value was 5.69 billion US dollars, a year-on-year increase o
New forces in international trade! Academician huangluqi, deputy director of the State Administration of traditional Chinese medicine, said at the forum that China has established overseas centers of traditional Chinese medicine in Morocco, Zimbabwe, Mauritius and other countries to serve the health
New forces in international trade! On June 25, the 7th summer summit of the World Conference on traditional Chinese medicine was held in Guiyang, Guizhou Province, with the theme of "inheritance, innovation, integration and development - promoting the high quality of traditional Chinese medicin
Driven by multiple forces such as policies and capital, my country's biomedicine has entered a stage of rapid development, and many places have regard this industry as a new economic growth point, and continue to increase their layout. In the context of increasing support for pharmaceutical inno
China approves the listing of 3 new drugsIn July, my country approved a total of 3 new drugs, of which 2 new drugs were independently developed by Chinese pharmaceutical companies.Carfilzomib is the third commercial product introduced in the strategic cooperation between BeiGene and Amgen. It is a s
Since the media Jindu Research Institute recently reported that Beijing Mingyan Space Technology Co., Ltd. ("Munyan Space"), the main body of the medical beauty business of Sihuan Pharmaceutical (00460.HK), sued a well-known pharmaceutical investment for infringement of trade secrets. The
"Economic Information Daily" reporter learned in Bozhou, Anhui, the largest Chinese medicinal material distribution center and price formation center, that multiple factors such as the epidemic, weather, and the implementation of the new version of the pharmacopoeia have led to an imbalanc
1. Volume of open coronary drug-coated balloons in 12 provinces including JiangsuYesterday (September 23). The Jiangsu Provincial Medical Security Bureau issued the "Announcement on the Procurement of the Volume of Coronary Drug-Coated Balloons of the Interprovincial Alliance (1)". The ann
A reporter from "Economic Information Daily" learned from Bozhou, Anhui, the largest Chinese medicinal material distribution center and price formation center, that multiple factors such as the epidemic situation, weather, and the implementation of the new version of the pharmacopoeia have
Focallure, a domestic cosmetics brand founded in Guangzhou, has recently received tens of millions of US dollars in Series A financing. The investors are Wuyuan Capital and XVC. Tianyancha APP shows that Feiluer received an angel round of financing in January 2021, and the investor is also Wuyuan Ca
